Clinical trial
Levetiracetam for Treatment of Pain Associated With Fibromyalgia
NCT00254657 · University of California, San Francisco, Other · Completed
Key facts
| NCT number | NCT00254657 |
|---|---|
| Title | Levetiracetam for Treatment of Pain Associated With Fibromyalgia |
| Official title | A Randomized, Double-Blind, Placebo-Controlled Trial of Levetiracetam for Treatment of Pain Associated With Fibromyalgia |
| Lead sponsor | University of California, San Francisco, Other |
| Collaborators | UCB Pharma Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Fibromyalgia |
| Intervention type | Drug |
| Interventions | Levetiracetam, Placebo |
| Enrollment | 66 |
| Start date | Mar 1, 2004 |
| Primary completion | Mar 1, 2005 |
| Completion | Apr 1, 2005 |
| First posted | Nov 16, 2005 |
| Last update posted | May 13, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: